[Ed. – Concerning. Order more, prime the pipeline, and keep the supply going to the states that need it. Even Fauci hasn’t flip-flopped on the treatment benefits of monoclonal antibodies.]
Alabama doctors are concerned about the impact on health care systems after the U.S. Department of Health and Human Services (HHS) decided to temporarily limit monoclonal antibody orders.
The summer’s surge in coronavirus cases prompted spikes in orders for monoclonal antibodies, and 70 percent of orders were being sent to just seven states. With a limited supply of doses, the HHS announced it was temporarily limiting the number of doses that could be ordered at any given time in an effort to ensure the treatment remains available for future patients.
Dr. Aruna Arora, president of the Medical Association of the State of Alabama, said in a statement that the announcement came at a time when Alabama’s hospitals are “full and under tremendous stress.” Given the level of hospitalizations the state is experiencing, physicians are “very concerned” about the move to limit supply and access, she said.
Trending: Cartoon of the Day: Biden Burnout